We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+11.45%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$76M
AUM Growth
-$11.1M
Cap. Flow
+$112M
Cap. Flow %
147.28%
Top 10 Hldgs %
38.02%
Holding
408
New
159
Increased
53
Reduced
54
Closed
131

Top Buys

Rank Stock Value
1
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$3.17M
2
K
Kellanova
K
+$2.19M
3
FL
Foot Locker
FL
+$2.04M
4
GIS icon
General Mills
GIS
+$1.95M
5
LULU icon
lululemon athletica
LULU
+$1.74M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$9.7M
2
JPM icon
JPMorgan Chase
JPM
+$3.58M
3
GILD icon
Gilead Sciences
GILD
+$3.38M
4
STZ icon
Constellation Brands
STZ
+$2.74M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 34.66%
2 Consumer Staples 16.16%
3 Consumer Discretionary 9.31%
4 Communication Services 3.38%
5 Materials 2.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CL icon
301
Colgate-Palmolive
CL
$73.4B
– –
-6,700
Closed -$469K
CLX icon
302
Clorox
CLX
$11.6B
– –
-7,862
Closed -$1.02M
CMG icon
303
CALL
Chipotle Mexican Grill
CMG
$42.2B
– –
-425,000
Closed -$37K
CMG icon
304
Chipotle Mexican Grill
CMG
$42.2B
– –
-74,600
Closed -$563K
CMG icon
305
PUT
Chipotle Mexican Grill
CMG
$42.2B
– –
-400,000
Closed -$79K
CPB icon
306
Campbell Soup
CPB
$6.52B
– –
-2,983
Closed -$180K
CPB icon
307
PUT
Campbell Soup
CPB
$6.52B
– –
-20,000
Closed -$33K
CRM icon
308
CALL
Salesforce
CRM
$140B
– –
-31,400
Closed -$2K
CRM icon
309
Salesforce
CRM
$140B
– –
-1,200
Closed -$82K
CRM icon
310
PUT
Salesforce
CRM
$140B
– –
-1,200
Closed -$17K
CTSH icon
311
CALL
Cognizant
CTSH
$21B
– –
-31,100
Closed -$58K
DVAX
312
DELISTED
Dynavax Technologies
DVAX
– –
-15,581
Closed -$74.9K
EPC icon
313
CALL
Edgewell Personal Care
EPC
$1.34B
– –
-16,500
Closed -$3K
EXEL icon
314
PUT
Exelixis
EXEL
$14.2B
– –
-43,500
Closed -$15K
FOLD
315
DELISTED
Amicus Therapeutics
FOLD
– –
-8,792
Closed -$55.6K
FOLD
316
PUT
DELISTED
Amicus Therapeutics
FOLD
– –
-10,000
Closed -$51K
GILD icon
317
Gilead Sciences
GILD
$166B
– –
-47,227
Closed -$3.38M
GILD icon
318
PUT
Gilead Sciences
GILD
$166B
– –
-134,000
Closed -$211K
GRMN
319
CALL
Garmin
GRMN
$47.5B
– –
-30,000
Closed -$18K
GRMN
320
PUT
Garmin
GRMN
$47.5B
– –
-10,000
Closed -$21K
HSY icon
321
PUT
Hershey
HSY
$34.6B
– –
-6,000
Closed -$39K
HUM icon
322
CALL
Humana
HUM
$47.7B
– –
-36,200
Closed -$406K
HUM icon
323
PUT
Humana
HUM
$47.7B
– –
-35,900
Closed -$54K
INFY icon
324
CALL
Infosys
INFY
$46.3B
– –
-89,200
Closed -$29K
ISRG icon
325
CALL
Intuitive Surgical
ISRG
$124B
– –
-298,800
Closed -$18K
11 12
13
14 15

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q1 2017 Portfolio in Review

As of Q1 2017, FT Options held 408 positions worth $76M, down 13% from $87.1M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options deployed $112M of net new capital in Q1 2017, opening 159 new positions and adding to 53 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 45% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $9.7M trimmed.

  • FT Options's largest Q1 2017 buy was GW Pharmaceuticals Plc American Depositary Shares: 25,829 shares worth $3.12M.
  • FT Options added most to Kellanova in Q1 2017, an estimated $2.19M increase.
  • FT Options's biggest Q1 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $9.7M.
  • FT Options fully exited JPMorgan Chase in Q1 2017, selling an estimated $3.58M.
  • FT Options's ten largest holdings make up 38% of its $76M portfolio in Q1 2017.
  • FT Options opened 159 new positions and closed 131 in Q1 2017.
  • FT Options's portfolio value fell 13% quarter-over-quarter to $76M.

Based on FT Options's 13F filing for Q1 2017, filed 12 May 2017.